A federal judge chose two lawyers Monday to serve as lead counsel in a putative class action against drug manufacturers and pharmacies alleging antitrust violations, following squabbling from several firms eager to take the leading role.
U.S. District Judge Brian Martinotti of the District of New Jersey appointed Steve Berman of Hagens Berman Sobol Shapiro and James Cecchi of Carella, Byrne, Cecchi, Olstein, Brody & Agnello to represent the putative class of patients with diabetes who purchased insulin from certain drugmakers.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]